BMC Cancer

official impact factor 3.15
Search for
Advanced search
BMC Cancer
Tools
Share this article
Open Access Highly Access Email this article to a friend

Response to gefitinib and erlotinib in Non-small cell lung cancer: a retrospective study

Ivette F Emery*, Chiara Battelli, Paul L Auclair, Kathleen Carrier and Daniel M Hayes

BMC Cancer 2009, 9:333 doi:10.1186/1471-2407-9-333

Fields marked * are required


Multiple email addresses should be separated with commas or semicolons.